
Dr. Reddy’s Q1 net inches up amid decline in generics sales to U.S.
The Hindu
Dr. Reddy’s Labs Q1 net profit rises slightly despite U.S. market decline, focus on strengthening base business.
More Related News

Dr. Reddy’s Labs Q1 net profit rises slightly despite U.S. market decline, focus on strengthening base business.